![Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era](https://pub.mdpi-res.com/biomedicines/biomedicines-10-01927/article_deploy/html/images/biomedicines-10-01927-g001.png?1660192940)
Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
![Cancers | Free Full-Text | Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens? Cancers | Free Full-Text | Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?](https://www.mdpi.com/cancers/cancers-14-06141/article_deploy/html/images/cancers-14-06141-g001.png)
Cancers | Free Full-Text | Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?
![IJMS | Free Full-Text | Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy IJMS | Free Full-Text | Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy](https://www.mdpi.com/ijms/ijms-23-14181/article_deploy/html/images/ijms-23-14181-g001.png)
IJMS | Free Full-Text | Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy
![Applied Sciences | Free Full-Text | The Use of Artificial Intelligence in Orthopedics: Applications and Limitations of Machine Learning in Diagnosis and Prediction Applied Sciences | Free Full-Text | The Use of Artificial Intelligence in Orthopedics: Applications and Limitations of Machine Learning in Diagnosis and Prediction](https://pub.mdpi-res.com/applsci/applsci-12-10775/article_deploy/html/images/applsci-12-10775-g001.png?1667295584)
Applied Sciences | Free Full-Text | The Use of Artificial Intelligence in Orthopedics: Applications and Limitations of Machine Learning in Diagnosis and Prediction
![Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm2007613/asset/images/large/jm-2011-007613_0019.jpeg)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry
![JPM | Free Full-Text | Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center JPM | Free Full-Text | Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center](https://www.mdpi.com/jpm/jpm-12-00955/article_deploy/html/images/jpm-12-00955-g001.png)